Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruben Pio

Showing results (51-60 of 99) with videos related to

Pageof 10
Sort By:
Cancer Letters|March 26, 2019
Targeting of TMPRSS4 sensitizes lung cancer cells to chemotherapy by impairing the proliferation machineryFrancisco Exposito, Maria Villalba, Miriam Redrado, et al.
Cancer Research|June 19, 2004
Alpha CP-4, encoded by a putative tumor suppressor gene at 3p21, but not its alternative splice variant alpha CP-4a, is underexpressed in lung cancerRuben Pio, Isabel Zudaire, Irene Pino, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 12, 2018
Biomarkers in Lung Cancer Screening: Achievements, Promises, and ChallengesLuis M Seijo, Nir Peled, Daniel Ajona, et al.
The Oncologist|May 17, 2011
Assessment of epidermal growth factor receptor and K-ras mutation status in cytological stained smears of non-small cell lung cancer patients: correlation with clinical outcomesMaria D Lozano, Javier J Zulueta, Jose I Echeveste, et al.
BMC Molecular Biology|November 19, 2008
Identification of importin 8 (IPO8) as the most accurate reference gene for the clinicopathological analysis of lung specimensPaul A Nguewa, Jackeline Agorreta, David Blanco, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 31, 2010
Complement factor H is elevated in bronchoalveolar lavage fluid and sputum from patients with lung cancerRuben Pio, Javier Garcia, Leticia Corrales, et al.
Cancer Discovery|March 15, 2017
A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and MetastasisDaniel Ajona, Sergio Ortiz-Espinosa, Haritz Moreno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2016
A Novel Epigenetic Signature for Early Diagnosis in Lung CancerAngel Diaz-Lagares, Jesus Mendez-Gonzalez, David Hervas, et al.
European Journal of Cancer (Oxford, England : 1990)|August 4, 2015
Stratification of resectable lung adenocarcinoma by molecular and pathological risk estimatorsEmad Rakha, Maria J Pajares, Marius Ilie, et al.
Plos One|March 24, 2015
Elevated levels of the complement activation product C4d in bronchial fluids for the diagnosis of lung cancerDaniel Ajona, Cristina Razquin, Maria Dolores Pastor, et al.
Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
Cancer Letters|March 26, 2019
Targeting of TMPRSS4 sensitizes lung cancer cells to chemotherapy by impairing the proliferation machineryFrancisco Exposito, Maria Villalba, Miriam Redrado, et al.
Cancer Research|June 19, 2004
Alpha CP-4, encoded by a putative tumor suppressor gene at 3p21, but not its alternative splice variant alpha CP-4a, is underexpressed in lung cancerRuben Pio, Isabel Zudaire, Irene Pino, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 12, 2018
Biomarkers in Lung Cancer Screening: Achievements, Promises, and ChallengesLuis M Seijo, Nir Peled, Daniel Ajona, et al.
The Oncologist|May 17, 2011
Assessment of epidermal growth factor receptor and K-ras mutation status in cytological stained smears of non-small cell lung cancer patients: correlation with clinical outcomesMaria D Lozano, Javier J Zulueta, Jose I Echeveste, et al.
BMC Molecular Biology|November 19, 2008
Identification of importin 8 (IPO8) as the most accurate reference gene for the clinicopathological analysis of lung specimensPaul A Nguewa, Jackeline Agorreta, David Blanco, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 31, 2010
Complement factor H is elevated in bronchoalveolar lavage fluid and sputum from patients with lung cancerRuben Pio, Javier Garcia, Leticia Corrales, et al.
Cancer Discovery|March 15, 2017
A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and MetastasisDaniel Ajona, Sergio Ortiz-Espinosa, Haritz Moreno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2016
A Novel Epigenetic Signature for Early Diagnosis in Lung CancerAngel Diaz-Lagares, Jesus Mendez-Gonzalez, David Hervas, et al.
European Journal of Cancer (Oxford, England : 1990)|August 4, 2015
Stratification of resectable lung adenocarcinoma by molecular and pathological risk estimatorsEmad Rakha, Maria J Pajares, Marius Ilie, et al.
Plos One|March 24, 2015
Elevated levels of the complement activation product C4d in bronchial fluids for the diagnosis of lung cancerDaniel Ajona, Cristina Razquin, Maria Dolores Pastor, et al.
Pageof 10